Carregant...

A Novel Calculator for Esophageal Adenocarcinoma Accurately Predicts Overall Survival Benefit from Neoadjuvant Chemoradiation

INTRODUCTION: Our group recently published that patients with clinically node negative (cN−) esophageal adenocarcinoma do not derive an overall survival (OS) benefit from neoadjuvant chemoradiation (nCRT) compared to clinically node positive (cN+) patients. The aim of this study was to develop a cal...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Am Coll Surg
Autors principals: Gabriel, Emmanuel, Attwood, Kristopher, Shah, Rupen, Hochwald, Steven, Kukar, Moshim, Nurkin, Steven
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5836490/
https://ncbi.nlm.nih.gov/pubmed/28147252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jamcollsurg.2017.01.043
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!